ArticleBreast cancer research : BCR2026

A systemic immune signature stratifies early-stage breast cancer patients and reveals soluble IL-2RA and PD-1 as potential independent prognostic biomarkers.

Yoel G Montoyo-Pujol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.